Q9UIS9 (MBD1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 124.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Methyl-CpG-binding domain protein 1 Alternative name(s): CXXC-type zinc finger protein 3 Methyl-CpG-binding protein MBD1 Protein containing methyl-CpG-binding domain 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 605 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Transcriptional repressor that binds CpG islands in promoters where the DNA is methylated at position 5 of cytosine within CpG dinucleotides. Binding is abolished by the presence of 7-mG that is produced by DNA damage by methylmethanesulfonate (MMS). Acts as transcriptional repressor and plays a role in gene silencing by recruiting AFT7IP, which in turn recruits factors such as the histone methyltransferase SETDB1. Probably forms a complex with SETDB1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Isoform 1 and isoform 2 can also repress transcription from unmethylated promoters. Ref.1 Ref.3 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 Ref.24 |
| Subunit structure | Interacts with the Ten-1 ICD form of TENM1 By similarity. Interacts with OASL, AFT7IP, AFT7IP2 and BAHD1. Binds CHAF1A and the SUV39H1-CBX5 complex via the MBD domain. Binds MGP via the TRD domain. May be part of the MeCP1 complex. During DNA replication, it recruits SETDB1 to form a S phase-specific complex that facilitates methylation of H3 'Lys-9' during replication-coupled chromatin assembly and is at least composed of the CAF-1 subunit CHAF1A, MBD1 and SETDB1. Ref.1 Ref.4 Ref.11 Ref.12 Ref.13 Ref.15 Ref.16 Ref.17 Ref.18 Ref.20 Ref.24 |
| Subcellular location | Nucleus By similarity. Nucleus matrix By similarity. Nucleus speckle. Chromosome. Note: Colocalizes with the Ten-1 ICD form of TENM1 in foci associated with the nuclear matrix By similarity. Nuclear, in a punctate pattern. Associated with euchromatic regions of the chromosomes, with pericentromeric regions on chromosome 1 and with telomeric regions from several chromosomes. Ref.1 Ref.3 Ref.10 Ref.11 Ref.14 Ref.24 |
| Tissue specificity | Widely expressed. Ref.1 |
| Induction | Up-regulated by interferon. Ref.4 |
| Domain | The methyl-CpG-binding domain (MBD) functions both in binding to methylated DNA and in protein interactions. The third CXXC-type zinc finger mediates binding to non-methylated CpG dinucleotides. The transcriptional repression domain (TRD) is involved in transcription repression and in protein interactions. |
| Post-translational modification | Sumoylated with SUMO1 by PIAS1 and PIAS3. Sumoylation affects transcriptional silencing by preventing the interaction with SETDB1. In contrast, sumoylation may increase interaction with AFT7IP. Ref.17 Ref.18 |
| Sequence similarities | Contains 3 CXXC-type zinc fingers. Contains 1 MBD (methyl-CpG-binding) domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CBX5 | P45973 | 5 | EBI-867196,EBI-78219 | |
| HDAC1 | Q13547 | 2 | EBI-867196,EBI-301834 | |
| HDAC2 | Q92769 | 2 | EBI-867196,EBI-301821 | |
| HDAC3 | O15379 | 3 | EBI-867196,EBI-607682 | |
| HTT | P42858 | 2 | EBI-867196,EBI-466029 | |
| PML-RAR | Q15156 | 4 | EBI-867196,EBI-867256 | |
| SUV39H1 | O43463 | 5 | EBI-867196,EBI-349968 |
Alternative products
| This entry describes 8 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9UIS9-1) Also known as: MBD1v1; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9UIS9-2) Also known as: MBD1v2; The sequence of this isoform differs from the canonical sequence as follows: 304-326: Missing. 483-528: Missing. 593-605: RSKDLKKPGARKQ → SLQGRHSGRE...RRSWCPSSQS | ||||||
| Isoform 4 (identifier: Q9UIS9-4) Also known as: MBD1v3; The sequence of this isoform differs from the canonical sequence as follows: 327-382: Missing. 483-528: Missing. | ||||||
| Isoform 5 (identifier: Q9UIS9-5) Also known as: PCM1; The sequence of this isoform differs from the canonical sequence as follows: 173-221: Missing. | ||||||
| Isoform 6 (identifier: Q9UIS9-6) Also known as: MBD1v6; The sequence of this isoform differs from the canonical sequence as follows: 483-528: Missing. 573-596: ITEIFSLGGTRFRDTAVWLPRSKD → EPTTQPQYSGNFDNDLYEIYLIDI 597-605: Missing. | ||||||
| Isoform 7 (identifier: Q9UIS9-7) The sequence of this isoform differs from the canonical sequence as follows: 327-382: Missing. | ||||||
| Isoform 8 (identifier: Q9UIS9-8) The sequence of this isoform differs from the canonical sequence as follows: 304-326: Missing. 483-528: Missing. | ||||||
| Isoform 9 (identifier: Q9UIS9-9) The sequence of this isoform differs from the canonical sequence as follows: 264-264: R → RHLAHRLRRRHQRCQRRTPLAVAPPT |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 605 | 605 | Methyl-CpG-binding domain protein 1 | PRO_0000096258 | |||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||
| Domain | 1 – 69 | 69 | MBD | ||||||||||||||||||||||||
| Zinc finger | 169 – 216 | 48 | CXXC-type 1 | ||||||||||||||||||||||||
| Zinc finger | 217 – 263 | 47 | CXXC-type 2 | ||||||||||||||||||||||||
| Zinc finger | 330 – 378 | 49 | CXXC-type 3 | ||||||||||||||||||||||||
| Region | 529 – 592 | 64 | TRD | ||||||||||||||||||||||||
| Motif | 84 – 88 | 5 | Nuclear localization signal Potential | ||||||||||||||||||||||||
| Compositional bias | 284 – 313 | 30 | Pro-rich | ||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||
| Modified residue | 399 | 1 | Phosphoserine Ref.19 Ref.21 | ||||||||||||||||||||||||
| Cross-link | 499 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.17 | |||||||||||||||||||||||||
| Cross-link | 538 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.17 | |||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||
| Alternative sequence | 173 – 221 | 49 | Missing in isoform 5. | VSP_011064 | |||||||||||||||||||||||
| Alternative sequence | 264 | 1 | R → RHLAHRLRRRHQRCQRRTPL AVAPPT in isoform 9. | VSP_042812 | |||||||||||||||||||||||
| Alternative sequence | 304 – 326 | 23 | Missing in isoform 2 and isoform 8. | VSP_011065 | |||||||||||||||||||||||
| Alternative sequence | 327 – 382 | 56 | Missing in isoform 4 and isoform 7. | VSP_011066 | |||||||||||||||||||||||
| Alternative sequence | 483 – 528 | 46 | Missing in isoform 2, isoform 4, isoform 6 and isoform 8. | VSP_011068 | |||||||||||||||||||||||
| Alternative sequence | 573 – 596 | 24 | ITEIF…PRSKD → EPTTQPQYSGNFDNDLYEIY LIDI in isoform 6. | VSP_011069 | |||||||||||||||||||||||
| Alternative sequence | 593 – 605 | 13 | RSKDL…GARKQ → SLQGRHSGREDGCKVWETED TVEPTSTSWNPRGWPGTHVS LSPPPASMMWVSCRRSWCPS SQS in isoform 2. | VSP_011070 | |||||||||||||||||||||||
| Alternative sequence | 597 – 605 | 9 | Missing in isoform 6. | VSP_011071 | |||||||||||||||||||||||
| Natural variant | 401 | 1 | P → A. Ref.2 Corresponds to variant rs125555 [ dbSNP | Ensembl ]. | VAR_019513 | |||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||
| Mutagenesis | 22 | 1 | R → A: Abolishes binding to methylated DNA. | ||||||||||||||||||||||||
| Mutagenesis | 30 | 1 | R → A: Strongly reduces binding to methylated DNA. Ref.23 | ||||||||||||||||||||||||
| Mutagenesis | 32 | 1 | D → A: Strongly reduces binding to methylated DNA. Ref.23 | ||||||||||||||||||||||||
| Mutagenesis | 34 | 1 | Y → A: Reduces binding to methylated DNA. Ref.23 | ||||||||||||||||||||||||
| Mutagenesis | 44 | 1 | R → A: Abolishes binding to methylated DNA. Ref.23 | ||||||||||||||||||||||||
| Mutagenesis | 45 | 1 | S → A: Slightly reduces binding to methylated DNA. Ref.23 | ||||||||||||||||||||||||
| Mutagenesis | 52 | 1 | Y → A: No effect. Ref.23 | ||||||||||||||||||||||||
| Mutagenesis | 64 | 1 | F → A: Disrupts tertiary structure and abolishes DNA binding. Ref.23 | ||||||||||||||||||||||||
| Mutagenesis | 499 | 1 | K → A: Abolishes sumoylation; when associated with A-538. Ref.17 | ||||||||||||||||||||||||
| Mutagenesis | 501 | 1 | E → A: Abolishes sumoylation; when associated with A-540. Ref.17 | ||||||||||||||||||||||||
| Mutagenesis | 538 | 1 | K → A: Abolishes sumoylation; when associated with A-499. Ref.17 | ||||||||||||||||||||||||
| Mutagenesis | 540 | 1 | E → A: Abolishes sumoylation; when associated with A-501. Ref.17 | ||||||||||||||||||||||||
| Mutagenesis | 576 | 1 | I → R: Abolishes interaction with AFT7IP and subsequent transcription repression activity. Ref.16 | ||||||||||||||||||||||||
| Sequence conflict | 239 | 1 | H → R in ABP02056. Ref.5 | ||||||||||||||||||||||||
| Sequence conflict | 330 | 1 | T → M in ABP02056. Ref.5 | ||||||||||||||||||||||||
| Sequence conflict | 348 – 349 | 2 | MD → NG in CAA71735. Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 348 – 349 | 2 | MD → NG in AAD51442. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 348 – 349 | 2 | MD → NG in AAD51443. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 489 | 1 | L → M in CAA71735. Ref.1 | ||||||||||||||||||||||||
| Isoform 7: | |||||||||||||||||||||||||||
| Sequence conflict | 327 | 1 | K → Q in AAD51444. Ref.3 | ||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||
| Beta strand | 5 – 7 | 3 | |||||||||||||||||||||||||
| Turn | 9 – 11 | 3 | |||||||||||||||||||||||||
| Beta strand | 16 – 19 | 4 | |||||||||||||||||||||||||
| Beta strand | 21 – 25 | 5 | |||||||||||||||||||||||||
| Beta strand | 33 – 36 | 4 | |||||||||||||||||||||||||
| Beta strand | 38 – 40 | 3 | |||||||||||||||||||||||||
| Helix | 47 – 53 | 7 | |||||||||||||||||||||||||
| Beta strand | 55 – 57 | 3 | |||||||||||||||||||||||||
| Turn | 64 – 66 | 3 | |||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins." Cross S.H., Meehan R.R., Nan X., Bird A. Nat. Genet. 16:256-259(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), FUNCTION, INTERACTION WITH THE MECP1 COMPLEX, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [2] | "Genomic structure and chromosomal mapping of the murine and human mbd1, mbd2, mbd3, and mbd4 genes." Hendrich B., Abbott C., McQueen H., Chambers D., Cross S.H., Bird A. Mamm. Genome 10:906-912(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT ALA-401. |
| [3] | "Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms." Fujita N., Takebayashi S., Okumura K., Kudo S., Chiba T., Saya H., Nakao M. Mol. Cell. Biol. 19:6415-6426(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 4 AND 7), FUNCTION, SUBCELLULAR LOCATION. Tissue: Fibroblast. |
| [4] | "Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1." Andersen J.B., Strandbygaard D.J., Hartmann R., Justesen J. Eur. J. Biochem. 271:628-636(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE (ISOFORM 6), INDUCTION BY INTERFERON, INTERACTION WITH OASL. Tissue: Leukocyte. |
| [5] | "New splice variant of the methyl-CpG binding protein 1 (MBD1)." Laget S.M., Xu S.-Y. Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8). Tissue: Cervix carcinoma. |
| [6] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 9). |
| [7] | "DNA sequence and analysis of human chromosome 18." Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J. Lander E.S.Nature 437:551-555(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7). Tissue: Prostate. |
| [9] | "Identification and characterization of a family of mammalian methyl-CpG binding proteins." Hendrich B., Bird A. Mol. Cell. Biol. 18:6538-6547(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 169-220, FUNCTION. |
| [10] | "Active repression of methylated genes by the chromosomal protein MBD1." Ng H.-H., Jeppesen P., Bird A. Mol. Cell. Biol. 20:1394-1406(2000) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [11] | "Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression." Fujita N., Watanabe S., Ichimura T., Tsuruzoe S., Shinkai Y., Tachibana M., Chiba T., Nakao M. J. Biol. Chem. 278:24132-24138(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH THE SUV39H1-CBX5 COMPLEX. |
| [12] | "MCAF mediates MBD1-dependent transcriptional repression." Fujita N., Watanabe S., Ichimura T., Ohkuma Y., Chiba T., Saya H., Nakao M. Mol. Cell. Biol. 23:2834-2843(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH AFT7IP. |
| [13] | "The methyl-CpG binding protein MBD1 interacts with the p150 subunit of chromatin assembly factor 1." Reese B.E., Bachman K.E., Baylin S.B., Rountree M.R. Mol. Cell. Biol. 23:3226-3236(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH CHAF1A. |
| [14] | "Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression." Ghoshal K., Majumder S., Datta J., Motiwala T., Bai S., Sharma S.M., Frankel W., Jacob S.T. J. Biol. Chem. 279:6783-6793(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [15] | "Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly." Sarraf S.A., Stancheva I. Mol. Cell 15:595-605(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH SETDB1 AND CHAF1A. |
| [16] | "Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins." Ichimura T., Watanabe S., Sakamoto Y., Aoto T., Fujita N., Nakao M. J. Biol. Chem. 280:13928-13935(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH AFT7IP AND AFT7IP2, MUTAGENESIS OF ILE-576. |
| [17] | "Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins." Lyst M.J., Nan X., Stancheva I. EMBO J. 25:5317-5328(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SETDB1, PHOSPHORYLATION, SUMOYLATION AT LYS-499 AND LYS-538, MUTAGENESIS OF LYS-499; GLU-501; LYS-538 AND GLU-540. |
| [18] | "Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation." Uchimura Y., Ichimura T., Uwada J., Tachibana T., Sugahara S., Nakao M., Saitoh H. J. Biol. Chem. 281:23180-23190(2006) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION, INTERACTION WITH AFT7IP. |
| [19] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Human BAHD1 promotes heterochromatic gene silencing." Bierne H., Tham T.N., Batsche E., Dumay A., Leguillou M., Kerneis-Golsteyn S., Regnault B., Seeler J.S., Muchardt C., Feunteun J., Cossart P. Proc. Natl. Acad. Sci. U.S.A. 106:13826-13831(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH BAHD1. |
| [21] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [22] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [23] | "Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1." Ohki I., Shimotake N., Fujita N., Nakao M., Shirakawa M. EMBO J. 18:6653-6661(1999) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 1-75 IN COMPLEX WITH METHYLATED DNA, MUTAGENESIS OF ARG-30; ASP-32; TYR-34; ARG-44; SER-45; TYR-52 AND PHE-64. |
| [24] | "Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin." Watanabe S., Ichimura T., Fujita N., Tsuruzoe S., Ohki I., Shirakawa M., Kawasuji M., Nakao M. Proc. Natl. Acad. Sci. U.S.A. 100:12859-12864(2003) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 1-75 IN COMPLEX WITH METHYLATED DNA, FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH MPG. |
| + | Additional computationally mapped references. |
Cross-references
Entry information
| Entry name | MBD1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9UIS9 Secondary accession number(s): A4UTZ0 Q9UNZ9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 18 Human chromosome 18: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
